Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06113705	Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.	recruiting	N/A	75	Istituto Clinico HumanitasOTHER	1	Jan 31, 2025	clinicaltrials
NCT05911230	Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases(AiD-GLIO)	recruiting	N/A	10	University Hospital, Basel, SwitzerlandOTHER	1	Jan 29, 2025